These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2546312)

  • 1. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.
    Berg C; Tiselius HG
    Urol Res; 1989; 17(3):167-72. PubMed ID: 2546314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyapatite induction and secondary aggregation of calcium oxalate, two important processes in calcium stone formation.
    Baumann JM; Affolter B; Caprez U; Henze U; Lauper D; Maier F
    Urol Res; 2001 Dec; 29(6):417-22. PubMed ID: 11828996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules.
    Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1999 Dec; 27(6):417-25. PubMed ID: 10651129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.
    Koutsoukos PG; Sheehan ME; Nancollas GH
    Invest Urol; 1981 Mar; 18(5):358-63. PubMed ID: 7203960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.
    Baumann JM; Lauber K; Lustenberger FX; Wacker M; Zingg EJ
    Urol Res; 1985; 13(4):169-74. PubMed ID: 4049602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Res; 1983; 11(4):151-4. PubMed ID: 6316611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques.
    Baumann JM; Wacker M
    Urol Res; 1979 Sep; 7(3):183-8. PubMed ID: 228455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary crystal growth: effect of inhibitor mixtures.
    Werness PG; Bergert JH; Lee KE
    Clin Sci (Lond); 1981 Oct; 61(4):487-91. PubMed ID: 6169479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate aggregation in whole urine, new aspects of calcium stone formation and metaphylaxis.
    Baumann JM; Affolter B; Caprez U; Henze U
    Eur Urol; 2003 Apr; 43(4):421-5. PubMed ID: 12667724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to studying inhibitors of calcium oxalate crystal growth.
    Hennequin C; Lalanne V; Daudon M; Lacour B; Drueke T
    Urol Res; 1993 Mar; 21(2):101-8. PubMed ID: 8389069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urolithiasis inhibitors and calculus nucleation.
    Grases F; Gil JJ; Conte A
    Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of calcium pyrophosphate and hydroxyapatite crystals on the production of oxygen free radicals by polymorphonuclear neutrophil leukocytes].
    Calabria AA; Parrini E; Bacarelli MR; Franci A; Gerli R; Cavallo G
    Boll Soc Ital Biol Sper; 1986 May; 62(5):691-7. PubMed ID: 3024674
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.